Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Glial contributions to neural function and disease.
Multiple sclerosis: summary of NICE guidance.
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population.
Response to disease modifying therapies in African Americans with multiple sclerosis.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography.
Emerging roles of exosomes in neuron-glia communication.
Immune surveillance in multiple sclerosis patients treated with natalizumab.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients

Pages